Methotrexate Solution
Product Images NDC 0143-9518

11 FDA label images from Hikma Pharmaceuticals Usa Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 11 technical images submitted to the FDA as part of the official labeling for Methotrexate (NDC 0143-9518). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hikma Pharmaceuticals Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Methotrexate Injection Usp 1)

Chemical Structure (Methotrexate Injection Usp 1)
Chemical structure of Methotrexate showing its molecular framework including a pteridine ring, amino groups, a benzene ring, and carboxyl functional groups.*
FDA Label Image

Ndc 0143-9519-01 Methotrexate Injection, Usp 50 mg Per 2 mL (25 mg/ml), 2 mL Single Dose Vial (Methotrexate Injection Usp 2)

Ndc 0143-9519-01 Methotrexate Injection, Usp 50 mg Per 2 mL (25 mg/ml), 2 mL Single Dose Vial (Methotrexate Injection Usp 2)
Methotrexate Injection, USP 25 mg/mL single-dose vial label by Hikma Pharmaceuticals USA Inc. This sterile toxic agent solution provides preservative-free methotrexate for intra-arterial, intramuscular, intrathecal, and intravenous use. The label includes barcode, storage instructions protecting from light and storing at 20 to 25 degrees Celsius, and warnings about prescribing information and dosage.*
FDA Label Image

Carton (Methotrexate Injection Usp 3)

Carton (Methotrexate Injection Usp 3)
Methotrexate Injection, USP 100 mg per 4 mL (25 mg/mL) solution for injection by intramuscular or subcutaneous use. The label states it is a cytotoxic agent and highlights warnings about dosing and medication errors. The labeler is Hikma Pharmaceuticals USA Inc., with NDC 0143-9518-01.*
FDA Label Image

Ndc 1043-9518-01 Methotrexate Injection, Usp, 100 mg Per 4 mL (25 mg/ml), 4 mL Single Dose Vial (Methotrexate Injection Usp 4)

Ndc 1043-9518-01 Methotrexate Injection, Usp, 100 mg Per 4 mL (25 mg/ml), 4 mL Single Dose Vial (Methotrexate Injection Usp 4)
Methotrexate Injection, USP 25 mg/mL solution in a single-dose vial. This preservative-free, sterile isotonic solution is labeled for intravenous, intramuscular, intrathecal, or subcutaneous use. The vial contains 8 mL, providing a total of 200 mg per vial. Manufactured by Hikma Pharmaceuticals USA Inc.*
FDA Label Image

Carton (Methotrexate Injection Usp 5)

Carton (Methotrexate Injection Usp 5)
Methotrexate Injection USP 25 mg per 10 mL (2.5 mg/mL) sterile isotonic solution in a vial. The label states it is preservative-free and intended for intravenous, intramuscular, intrathecal, or subcutaneous use. It includes warnings about dosage and storage conditions. Labeler is Hikma Pharmaceuticals USA Inc.*
FDA Label Image

Ndc 0143-9517-01 Methotrexate Injection, Usp, 200 mg Per 8 mL (25 mg/ml), 8 mL Single Dose Vial (Methotrexate Injection Usp 6)

Ndc 0143-9517-01 Methotrexate Injection, Usp, 200 mg Per 8 mL (25 mg/ml), 8 mL Single Dose Vial (Methotrexate Injection Usp 6)
Label panel displaying a QR code and alphanumeric identifiers including GTIN, serial number, expiration date placeholder, and lot number placeholder for Methotrexate 25 mg/mL solution by Hikma Pharmaceuticals USA Inc.*
FDA Label Image

Carton (Methotrexate Injection Usp 7)

Carton (Methotrexate Injection Usp 7)
Label for Methotrexate solution 25 mg/mL by Hikma Pharmaceuticals USA Inc. The label includes a 2D barcode, a lot number, expiration date, GTIN (Global Trade Item Number), and a serial number. The label is designed for identification and traceability purposes.*
FDA Label Image

Ndc 0143-9516-01 Methotrexate Injection, Usp, 250 mg Per 10 mL (25 mg/ml), 10 mL Single Dose Vail (Methotrexate Injection Usp 8)

Ndc 0143-9516-01 Methotrexate Injection, Usp, 250 mg Per 10 mL (25 mg/ml), 10 mL Single Dose Vail (Methotrexate Injection Usp 8)
Methotrexate Injection, USP sterile isotonic solution with a concentration of 25 mg per 10 mL (25 mg/mL). The label states it is preservative-free and intended for intravenous, intramuscular, intrathecal, or subcutaneous use in 10 mL single dose vials. The product is distributed by Hikma Pharmaceuticals USA Inc. and includes a warning to see the package insert for full prescribing information and boxed warning.*
FDA Label Image

Carton (Methotrexate Injection Usp 9)

Carton (Methotrexate Injection Usp 9)
Packaging label for Methotrexate Injection, USP Solution 25 mg/mL (250 mg per 10 mL) by Hikma Pharmaceuticals USA Inc. The label identifies it as a preservative-free cytotoxic agent, instructs protection from light and storage at 20° to 25°C. It is a single dose vial, 10 mL, with warnings on blood count monitoring and possible side effects. Manufactured in Germany and distributed by Hikma Pharmaceuticals USA.*
FDA Label Image

Serialization Image 2ml Carton (Methotrexate Injection Usp 10)

Serialization Image 2ml Carton (Methotrexate Injection Usp 10)
A rectangular label featuring a QR code on the left side. To the right of the QR code are text fields displaying a GTIN number, a serial number (SN), an expiration date labeled 'EXP,' and a lot number (LOT). The label is simple, black text on a white background, without additional branding or color.*
FDA Label Image

Serialization Image (4mL, 8mL, and 10mL Carton)

Serialization Image (4mL, 8mL, and 10mL Carton)
Label for Methotrexate solution showing a 2D barcode on the left and printed text fields indicating lot number (ABCDE12345), expiration date (MMMYYYY), a GTIN code, and a serial number. The label is intended for pharmaceutical product identification and traceability.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.